Jichao Wei
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- FOXO transcription factor regulation 3
- Surgery 7
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
- Co-authors
- Fandi Meng (16 shared papers)Kai Qu (7 shared papers)Kai Qu (9 shared papers)Qifei Wu (6 shared papers)Ming‐Hui Tai (10 shared papers)Xinsen Xu (7 shared papers)Hulin Chang (7 shared papers)Zhixin Wang (2 shared papers)
- Journals
- Acta Pharmacologica Sinica (2 papers)Scientific Reports (1 paper)European Journal of Gastroenterology & Hepatology (1 paper)Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (1 paper)The International Journal of Biological Markers (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Jichao Wei
22 papers receiving 551 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 179
- Hepatology 58
- Oncology 121
- Molecular Biology 300
- Aging 7
Countries citing papers authored by Jichao Wei
This map shows the geographic impact of Jichao Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jichao Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jichao Wei more than expected).
Fields of papers citing papers by Jichao Wei
This network shows the impact of papers produced by Jichao Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jichao Wei. The network helps show where Jichao Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Jichao Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 87 | |
| 2 | 2013 | 86 | |
| 3 | 2015 | 82 | |
| 4 | 2012 | 61 | |
| 5 | 2014 | 37 | |
| 6 | Cisplatin induces cell cycle arrest and senescence via upregulating P53 and P21 expression in HepG2 cells. | 2013 | 32 |
| 7 | 2019 | 29 | |
| 8 | 2012 | 26 | |
| 9 | 2013 | 17 | |
| 10 | 2014 | 16 | |
| 11 | 2012 | 14 | |
| 12 | 2012 | 12 | |
| 13 | 2013 | 10 | |
| 14 | 2012 | 10 | |
| 15 | 2014 | 9 | |
| 16 | 2012 | 8 | |
| 17 | 2011 | 6 | |
| 18 | 2023 | 6 | |
| 19 | 2025 | 3 | |
| 20 | 2016 | 3 |
About Jichao Wei
Jichao Wei is a scholar working on Molecular Biology, Surgery, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 22 papers that have together received 557 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), MicroRNA in disease regulation (3 papers), FOXO transcription factor regulation (3 papers), Gallbladder and Bile Duct Disorders (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer, Lipids, and Metabolism (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (179 citations), Hepatology (58 citations), Oncology (121 citations), Molecular Biology (300 citations) and Aging (7 citations). Jichao Wei has collaborated with scholars based in China and United States. Frequent co-authors include Fandi Meng, Kai Qu, Kai Qu, Qifei Wu, Ming‐Hui Tai, Xinsen Xu, Hulin Chang, Zhixin Wang, Qing Pang and Chang Liu. Their work appears in journals such as Acta Pharmacologica Sinica, Scientific Reports, European Journal of Gastroenterology & Hepatology, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics and The International Journal of Biological Markers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.